2013-01-01Zeitschriftenartikel DOI: 10.1007/978-3-642-33570-9_11
Complexity of Botulinum Neurotoxins: Challenges for Detection Technology
The detection of botulinum neurotoxins (BoNT) is extremely challenging due to their high toxicity and the multiple BoNT variants. To date, seven serotypes with more than 30 subtypes have been described, and even more subtypes are expected to be discovered. The fact that the BoNT molecules are released as large complexes of different size and composition adds further complexity to the issue. Currently, in the diagnostics of botulism, the mouse bioassay (MBA) is still considered as gold standard for the detection of BoNT in complex sample materials. Over the years, different functional, immunological, and spectrometric assays or combinations thereof have been developed, supplemented by DNA-based assays for the detection of the organism. In this review, advantages and limitations of the current technologies will be discussed, highlighting some of the intricacies of real sample analysis.
Dateien zu dieser Publikation
Anzeige der Publikationen mit ähnlichem Titel, Autor, Urheber und Thema.
2010-04-02ZeitschriftenartikelThe Case of Botulinum Toxin in Milk: Experimental Data Weingart, Oliver G.; Schreiber, Tanja; Mascher, Conny; Pauly, Diana; Dorner, Martin; Berger, Thomas F. H.; Egger, Charlotte; Gessler, Frank; Loessner, Martin J.; Avondet, Marc-André; Dorner, BrigitteBotulinum neurotoxin (BoNT) is the most toxic substance known to man and the causative agent of botulism. Due to its high toxicity and the availability of the producing organism Clostridium botulinum, BoNT is regarded as ...
2015-02-06ZeitschriftenartikelIsolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype Kull, Skadi; Schulz, Melanie; Strotmeier, Jasmin Weisemann née; Kirchner, Sebastian; Schreiber, Tanja; Bollenbach, Alexander; Dabrowski, Piotr Wojtek; Nitsche, Andreas; Kalb, Suzanne R.; Dorner, Martin; Barr, John R.; Rummel, Andreas; Dorner, BrigitteBotulism is a severe neurological disease caused by the complex family of botulinum neurotoxins (BoNT). Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed ...
2012-11-09ZeitschriftenartikelSerum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols Filbert, Helene; Attig, Sebastian; Bidmon, Nicole; Renard, Bernhard Y.; Janetzki, Sylvia; Sahin, Ugur; Welters, Marij J. P.; Ottensmeier, Christian; Burg, Sjoerd H. van der; Gouttefangeas, Cécile; Britten, Cedrik M.Robust and sensitive ELISPOT protocols are commonly applied concomitant with the development of new immunotherapeutics. Despite the knowledge that individual serum batches differ in their composition and may change properties ...